80. Optimization of tacrolimus in kidney transplantation: New pharmacokinetic perspectives. Transplant Rev (Orlando). 2020, 34(2):100531
Oberbauer R, Bestard O, Furian L, Maggiore U, Pascual J, Rostaing L, Budde K.
// Publications
78. Response to: “Biostatistics pitfalls: Lessons learned from analysis of medical data” by Yin et al. Contemp Clin Trials. 2020, 89:105916
Reindl-Schwaighofer R, Heinzel A, Heinze G, Kammer M, Oberbauer R
76. Summary of the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation. Transplantation. 2020, 104(4):708-714
Chadban SJ, Ahn C, Axelrod DA, Foster BJ, Kasiske BL, Kher V, Kumar D, Oberbauer R, Pascual J, Pilmore HL, Rodrigue JR, Segev DL, Sheerin NS, Tinckam KJ, Wong G, Balk EM, Gordon CE, Earley A, Rofeberg V, Knoll GA
75. Deceased donor kidney allocation schemes and international exchange. Curr Opin Organ Transplant. 2020, 25(1):66-73
Heemann U, Oberbauer R, Sprangers B, Gökalp C, Bemelman F; Eurotransplant Kidney Advisory Committee.
74. Novel insights into Non-HLA Alloimmunity in Kidney Transplantation. Transpl Int. 2020, 33:5-17
Reindl-Schwaighofer R, Heinzel A, Gualdoni GA, Mesnard L, Claas FHJ, Oberbauer R.
73. To test or to estimate? P-values versus effect sizes. Transpl Int. 2020, 33(1):50-55
Dunkler D, Haller M, Oberbauer R, Heinze G.